These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Quality of life and hematocrit level. Levin NW Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):16-20. PubMed ID: 1626552 [TBL] [Abstract][Full Text] [Related]
23. Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing. Keen ML ANNA J; 1990 Aug; 17(4):318-9. PubMed ID: 2396859 [TBL] [Abstract][Full Text] [Related]
24. Epoetin alfa--focus on dialyzability. Case study of the anemic patient. Keen ML ANNA J; 1995 Dec; 22(6):610-3. PubMed ID: 8633909 [TBL] [Abstract][Full Text] [Related]
25. Case study of the anemic patient: epoetin alfa--focus on improving ventricular function. Weil C ANNA J; 1995 Jun; 22(3):338-41. PubMed ID: 7786083 [TBL] [Abstract][Full Text] [Related]
26. Case management of the anemic patient. Epoetin alfa: focus on oral iron supplementation. Sasak C ANNA J; 1991 Oct; 18(5):508-9. PubMed ID: 1953090 [TBL] [Abstract][Full Text] [Related]
27. Epoetin alfa: focus on inflammation and infection. Case study of the anemic patient. Chambers JK ANNA J; 1998 Jun; 25(3):353-6. PubMed ID: 9801493 [TBL] [Abstract][Full Text] [Related]
28. Epoetin alfa--focus on patients who are hospitalized. Case study of the anemic patient. Chambers JK ANNA J; 1996 Oct; 23(5):508-11. PubMed ID: 9069780 [TBL] [Abstract][Full Text] [Related]
29. Case management of the anemic patient epoetin alfa: focus on aluminum management. Lowrey S ANNA J; 1991 Feb; 18(1):56-7. PubMed ID: 2003757 [TBL] [Abstract][Full Text] [Related]
30. Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient. Watson C ANNA J; 1999 Dec; 26(6):629-32. PubMed ID: 10876477 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment. Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R; Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642 [TBL] [Abstract][Full Text] [Related]
32. Developing an anemia management protocol. Case study of the anemic patient. Hossli S ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110 [TBL] [Abstract][Full Text] [Related]
33. Case management of the anemic patient. Epoetin alfa: focus on nutrition management. Hensley MK ANNA J; 1990 Oct; 17(5):390-1. PubMed ID: 2241257 [TBL] [Abstract][Full Text] [Related]
34. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. Eschbach JW J Am Soc Nephrol; 2002 May; 13(5):1412-4. PubMed ID: 11961032 [No Abstract] [Full Text] [Related]
35. Clinical administration of epoetin alfa recombinant. Taylor BA; Weinstein SM J Intraven Nurs; 1992; 15(2):78-82. PubMed ID: 1564606 [TBL] [Abstract][Full Text] [Related]
36. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Jones M; Ibels L; Schenkel B; Zagari M Kidney Int; 2004 Mar; 65(3):757-67. PubMed ID: 14871396 [TBL] [Abstract][Full Text] [Related]
37. Epoetin alfa--focus on the geriatric patient. Case study of the anemic patient. Mathers T ANNA J; 1995 Oct; 22(5):494-7. PubMed ID: 7487195 [TBL] [Abstract][Full Text] [Related]
38. Health care outcomes case study: anemia in end-stage renal disease. Turco TF Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S19-23. PubMed ID: 8846242 [TBL] [Abstract][Full Text] [Related]
39. Managing anemia using laboratory trend analysis. Case study of the anemic patient. Aiello J ANNA J; 1999 Aug; 26(4):430-3. PubMed ID: 10838975 [TBL] [Abstract][Full Text] [Related]